Fennec (FENC) 2026 Earnings: Q1 Outlook and Takeaways
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Ways To Increase Retirement Savings After 50
Explore various ways to increase retirement savings after 50. Enhance your financial security with these methods.
21,993 articles
Robo-advisor Comparison 2026: Navigating the IPO Wave
The IPO market is shifting in 2026, and smart investors are turning to robo-advisors to balance access and risk. Lear...
Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Pembroke Trims Position Workiva: What Investors Should Know
A major fund reshaped its Workiva stake in a recent SEC filing, signaling routine portfolio rebalancing rather than a...
Hilton Capital Sells Million: Interpreting GPIX Trim
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Live: Will Marvell Soar Tonight After Q1 Earnings?
Marvell Technology is set to report fiscal Q1 results after the close, with investors weighing AI demand, margins and...
Palantir Soars as Dell Earnings Beat Validates AI Pact
Dell Technologies beats expectations, validating its AI-focused partnership with Palantir and sending Palantir shares...
Why a Fund Walked Away From a $20 Million China Bet
A high-conviction bet on a Chinese logistics platform faced a sharp stock drop. This article explains why the fund wa...
Following Token-Dumping Scandal, Movement Rebrands
Movement pivots from a speculative token project to a Layer 1 blockchain, backed by Circle and other partners, as it ...
Meta Platforms Stock Crushed: Why Investors Are Upbeat Today
Meta Platforms stock crushed the market today as Meta rolled out a business-focused AI tool worldwide. Investors weig...
Morning Minute: Massive Zcash Exploit Shocks Crypto Markets
This morning’s update centers on a massive Zcash exploit found by a security researcher. The flaw may have lingered f...
Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status